A new gene-expression mechanism is a minor thing of major importance

Aug 21, 2013
This is a Minor Intron Splicing. Credit: Gideon Dreyfuss, PhD, Perelman School of Medicine, University of Pennsylvania

A rare, small RNA turns a gene-splicing machine into a switch that controls the expression of hundreds of human genes. Howard Hughes Medical Institute Investigator and professor of Biochemistry Gideon Dreyfuss, PhD, and his team from the Perelman School of Medicine at the University of Pennsylvania, discovered an entirely new aspect of the gene-splicing process that produces messenger RNA (mRNA).

The investigators found that a scarce, small RNA, called U6atac, controls the expression of hundreds of genes that have critical functions in cell growth, cell-cycle control, and global control of physiology. Their results were published in the journal eLife.

These genes encode proteins that play essential roles in cell physiology such as several transcription regulators, ion channels, signaling proteins, and DNA damage-. Their levels in cells are regulated by the activity of the splicing machinery, which acts as a valve to control essential regulators of cell growth and response to .

Dreyfuss, who studies RNA-binding proteins and their role in such diseases as and other motor neuron , describes the findings as "completely unanticipated."

Complicated Splicing

As DNA is transcribed into RNA and then into the various proteins that perform the functions of life, non-coding (introns) need to be removed from the transcribed RNA strand and the remaining gene sequences (exons) joined together. This is the job of specialized called the spliceosome. There are two varieties of spliceosomes, the so-called major and minor. The major spliceosome is by far the most abundant, such that the role of its minor counterpart is often disregarded.

"Most of the time the minor spliceosome, which has similar but not identical components to that of the major, isn't even mentioned," says Dreyfuss. With each type of spliceosome recognizing different splicing cues, the major spliceosome acts on the vast majority of introns (>200,000) and the minor one splices the several hundred minor-type introns.

But the evolutionary persistence and role of the minor spliceosome has been a puzzle to scientists, since the minor introns it targets are far outnumbered by the major introns handled by the major spliceosome, and the minor spliceosome is often inefficient. But the mRNAs produced from genes that have a minor intron are not ready until all their introns, both major and minor, are spliced. Thus a single inefficiently spliced minor intron can hold up expression – mRNA and protein production – for an entire gene. Researchers have therefore wondered why the apparently superfluous minor spliceosome hasn't been eliminated altogether through normal evolution.

"One looks at it and asks, we've known that minor spliceosomes are inefficient, why even bother to keep them under evolution's relentless selection pressure?" notes Dreyfuss. "It's been difficult to rationalize the conservation of minor introns and the minor spliceosome on the basis of splicing alone, as with few cue changes this function could simply have been performed by the major spliceosome."

More to the Minor

Dreyfuss's team discovered that there's more to the minor spliceosome while investigating the effects of different physiological conditions such as cell stress, transcription, and protein synthesis on small noncoding RNAs. "We inhibited transcription and then measured what happens to the amount of each of the small noncoding RNAs three or four hours later," he explains. "That's when we noticed that U6atac levels plunged." They found that U6atac, which is also the catalytic component of the minor spliceosome, is extremely unstable in a cell. "If you stop the transcription of U6atac, you stop producing it, and very quickly its levels become terribly low. And we knew that it's already one of the rarest snRNAs in cells. So we thought this surely will have an effect on minor intron splicing."

To test for such effects, the researchers deliberately knocked down U6atac in cells and then did genome-wide RNA sequencing. "We noticed that when you knock down U6atac, each minor intron responds differently," notes Dreyfuss. "Some of them showed that they're very inefficient and highly sensitive to U6atac level, which is an explanation for why the mRNA from those genes doesn't express well." Low U6atac levels within cells limit the rate of minor intron splicing, and thus the expression of important genes containing those minor introns.

Next, says Dreyfuss, "we started looking for any conditions where the levels of U6atac might be increased, so that the less efficient genes will be able to express. Out of the various conditions that we surveyed, we found that cell stress, which activates the p38MAPK pathway, causes a very large and rapid increase in U6atac and with that, a huge enhancement of the splicing of those minor introns that otherwise splice very inefficiently." (p38MAPK is a key component of cell signaling pathways that are activated during cell stress such as the release of inflammatory cytokines, ultraviolet radiation, heat, and osmotic shocks, so p38MAPK play an important role in cellular growth and differentiation, apoptosis, cancer, and autophagy).

A Valve and a Splicer

Sure enough, when U6atac levels are rapidly and steeply increased, "the bottleneck to the production of mRNA from those few hundred genes that contain a minor intron is removed." The p38MAPK signaling pathway – when activated under cell stress—is one of potentially many ways in which U6atac levels can be modulated.

When minor spliceosome activity is reduced, the minor introns are retained in the mRNA while the major introns are spliced out. This signals the mRNA for degradation, limiting the expression of genes that contain minor introns.

The findings point to an entirely new and vital role for the minor spliceosome and particularly its U6atac component. More than simply splicing out minor introns, U6atac actually functions as a control and regulatory mechanism for minor intron-containing genes. "We propose that the minor spliceosome was conserved because it's used as a valve, not simply a spliceosome," Dreyfuss says. "It's a very important switch and it's an unexpected kind of mechanism."

Dreyfuss sees parallels between the discovery of U6atac's role in splicing and previous work by his lab that revealed the importance of U1, a major component, in preventing the premature termination of mRNA transcription. "That was completely unanticipated and is a major area of interest, because this is a major way of regulating the transcriptome and mRNA length."

One of the team's next steps will be to determine exactly how p38MAPK, and possibly other molecules, acts to control U6atac levels.

Meanwhile, they have demonstrated the "folly" of casually disregarding the seemingly unimportant. "This provides a new perspective on minor introns and minor spliceosomes, because it's been a real mystery," says Dreyfuss.

Explore further: Enzyme that unravels RNA molecules has crucial role in plant development

Related Stories

Editing-molecule mutation causes fatal primordial dwarfism

Apr 07, 2011

Fetuses with defects in a molecular machine that edits information cells use to make proteins can develop a rare form of dwarfism, according to a new study led by researchers at the Ohio State University Comprehensive Cancer ...

How 'junk DNA' can control cell development

Aug 02, 2013

Researchers from the Gene and Stem Cell Therapy Program at Sydney's Centenary Institute have confirmed that, far from being "junk", the 97 per cent of human DNA that does not encode instructions for making proteins can play ...

New mechanism in the regulation of human genes

Jul 14, 2011

Scientists at the Technical University of Munich and the Helmholtz Zentrum Muenchen and along with their colleagues from the European Molecular Biology Laboratory (EMBL) in Heidelberg and the Centre for Genomic Regulation ...

Temperature controls the genetic message

Sep 16, 2011

Alternative splicing, the mechanism enabling a gen to encode different proteins, according to the cell's needs, still holds many secrets. It has transformed the initial theory of one gen, one protein, but how it is controlled ...

Recommended for you

Researchers successfully clone adult human stem cells

Apr 18, 2014

(Phys.org) —An international team of researchers, led by Robert Lanza, of Advanced Cell Technology, has announced that they have performed the first successful cloning of adult human skin cells into stem ...

Researchers develop new model of cellular movement

Apr 18, 2014

(Phys.org) —Cell movement plays an important role in a host of biological functions from embryonic development to repairing wounded tissue. It also enables cancer cells to break free from their sites of ...

User comments : 0

More news stories

Biologists help solve fungi mysteries

(Phys.org) —A new genetic analysis revealing the previously unknown biodiversity and distribution of thousands of fungi in North America might also reveal a previously underappreciated contributor to climate ...

Finnish inventor rethinks design of the axe

(Phys.org) —Finnish inventor Heikki Kärnä is the man behind the Vipukirves Leveraxe, which is a precision tool for splitting firewood. He designed the tool to make the job easier and more efficient, with ...

Making graphene in your kitchen

Graphene has been touted as a wonder material—the world's thinnest substance, but super-strong. Now scientists say it is so easy to make you could produce some in your kitchen.